Investigation and Study on the Status of Endovascular Therapy in Acute Ischemic Stroke Ischemic Stroke

NCT03909438 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-04-13

No results posted yet for this study

Summary

This study aims to build a database for patients with acute ischemic stroke who receive endovascular therapy and analyze the current situation, effectiveness, safety and cost-effectiveness of endovascular therapy for acute ischemic stroke in China.

Conditions

Interventions

PROCEDURE

Endovascular Thrombectomy

Endovascular therapy includes direct mechanical thrombectomy or intravenous thrombolysis with mechanical thrombectomy. Endovascular Thrombectomy Device: Trepo trevor Retriever Device: SolitaireTM FR Revascularization Device

Sponsors & Collaborators

  • Fourth Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator UNKNOWN
  • Taizhou Hospital

    collaborator OTHER
  • Lishui Country People's Hospital

    collaborator OTHER
  • The Central Hospital of Lishui City

    collaborator OTHER
  • Shaoxing People's Hospital

    collaborator OTHER
  • Ganzhou People's Hospital

    collaborator UNKNOWN
  • Luoyang Central Hospital

    collaborator OTHER
  • Huizhou Municipal Central Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Jiaxing University

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • The First People's Hospital of Huzhou

    collaborator OTHER
  • Taizhou First People's Hospital

    collaborator OTHER
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Min Lou, Ph.D · Second Affiliated Hospital, School of Medicine, Zhejiang University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2024-06-30
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03909438 on ClinicalTrials.gov